Stocks-ZNTL-Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Inc ZNTL

Name: Zentalis Pharmaceuticals Inc
SKU: ZNTL
Price: 3.01 USD
Availability: InStock

‎$‎3.010.06(2.03%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Zentalis Pharmaceuticals Inc
Today

Create an eToro account to buy ZNTL stock on a secure, user-friendly, multi-asset trading platform.

Zentalis Pharmaceuticals Inc ZNTL

Buy ZNTL

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Sinotruk Hong Kong Ltd

MAX

*Past performance is not an indication of future results

Jump to:

About ZNTL >
How to Buy? >
Top Guides >

The Zentalis Pharmaceuticals Inc share price is on the decline this week.

The Zentalis Pharmaceuticals Inc share price today is ‎$‎3.01, reflecting a ‎2.03‎% change over the last 24 hours and ‎-4.60‎% over the past week. The current market capitalization of ZNTL is ‎$‎213.14M with an average volume in the last three months of 1.32M. The stock has a P/E ratio of -1.42 and a dividend yield of 0%. With the stock’s beta sitting at 1.6

ZNTL Key Metrics

Market Cap

‎$‎213.14M

Day’s Range

‎$‎2.83 - ‎$‎3.08

52W Range

‎$‎1 - ‎$‎5.42

Average Volume (3M)

1.32M

Price-Earnings Ratio

-1.42

Revenue

‎$‎26.87M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎2.95

EPS

‎$‎-2.08

Beta

1.6

How can I buy Zentalis Pharmaceuticals Inc stocks?

To purchase Zentalis Pharmaceuticals Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Zentalis Pharmaceuticals Inc (ZNTL) page and place an order to buy Zentalis Pharmaceuticals Inc.

Buy ZNTL

Looking for more information? Check out our guide on Academy.

What Is Zentalis Pharmaceuticals Inc?

Zentalis Pharmaceuticals Inc is a key player in the global biopharmaceutical arena, dedicated to bringing transformative medicines to patients with the aid of ground-breaking oncology research and clinical capabilities. The company primarily operates across the US.

Zentalis operates within the healthcare sector, offering a spectrum of patient-centric solutions with a core emphasis on cancer diagnosis, treatment and preventive care. It has invested significantly in research and development endeavours to pioneer impactful innovations within the healthcare domain.

Stay up to date on the share price of ZNTL by adding it to your eToro watchlist.

CEO

Julia Marie Eastland, MBA

Employees

166

Founded

2014

San Diego, California, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Zentalis Pharmaceuticals Inc
Today

Create an eToro account to buy ZNTL stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Zentalis Pharmaceuticals Inc stock?

The current price of ZNTL is ‎$‎3.01.

What are analysts’ forecasts for Zentalis Pharmaceuticals Inc?

Analysts offer forecasts for Zentalis Pharmaceuticals Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Zentalis Pharmaceuticals Inc?

The market capitalisation of Zentalis Pharmaceuticals Inc is ‎$‎213.14M

Daily Movers

Explore the biggest stocks movers on the market.